Elective Naloxone-Induced Opioid Withdrawal for Rapid Initiation of Medication-Assisted Treatment of Opioid Use Disorder - 23/08/19
, Matthew Salzman, MD, Rachel Haroz, MD, Rachel Rafeq, PharmD, Anthony J. Mazzarelli, MD, JD, Alexis Pelletier-Bui, MDAbstract |
We present a case of elective naloxone-induced opioid withdrawal followed by buprenorphine rescue to initiate opioid use disorder treatment in the emergency department. This strategy may represent a safe alternative to prescribing buprenorphine for outpatient initiation, a method that puts the patient at risk for complications of unmonitored opioid withdrawal, including relapse. After confirmation that the naloxone-induced withdrawal was adequately treated with buprenorphine, the patient was discharged with prescribed buprenorphine to follow up in an addiction medicine clinic, where he was treated 2 days later.
Le texte complet de cet article est disponible en PDF.Plan
| Supervising editor: Richard C. Dart, MD, PhD. Specific detailed information about possible conflict of interest for individual editors is available at editors. |
|
| Authorship: All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. |
|
| Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. |
Vol 74 - N° 3
P. 430-432 - septembre 2019 Retour au numéro
Article précédent
- Efficacy of Oral Administration of Sodium Thiosulfate and Glycine in a Large, Swine Model of Oral Cyanide Toxicity
- Patrick C. Ng, Tara B. Hendry-Hofer, Alyssa E. Witeof, Sari B. Mahon, Matthew Brenner, Gerry R. Boss, Vikhyat S. Bebarta
- Balancing Benefits and Harms on the Frontier of Buprenorphine Initiation
- Reuben J. Strayer, Andrew A. Herring, Lewis S. Nelson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?